TERSERA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 06 Feb 2025)
What this means for you
Registered since 16 Jul 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86900298
- Registration number
- 5807179
- Mark type
- Stylized text
- Filed
- 08 Feb 2016
- Published for opposition
- 28 Jun 2016
- Registered
- 16 Jul 2019
- Attorney of record
- Mitchell J. Weinstein
Goods and services
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; pharmaceutical research and development and related services, namely, pharmaceutical drug development services
Owner
- Tersera Therapeutics LLC, Deerfield, IL, US
- Tersera Therapeutics LLC, Lake Forest, IL, US
- Tersera Therapeutics LLC, Chicago, IL, US
Prosecution history
- 06 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 06 Feb 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 05 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Jan 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 20 Sept 2024 — TEAS SECTION 8 & 15 RECEIVED
- 16 Jul 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 16 Jul 2019 — REGISTERED-PRINCIPAL REGISTER
- 13 Jun 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Jun 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Jun 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 21 May 2019 — USE AMENDMENT FILED
- 02 Jun 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 May 2019 — TEAS STATEMENT OF USE RECEIVED
- 29 Dec 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Dec 2018 — SOU EXTENSION 4 GRANTED